BDBM766044 N-[(4-fluorophenyl)methyl]-2-[(1''S)-5''-{1-[1-(oxetan-3-yl)azetidin-3-yl]-1H-pyrazol-4-yl}-2,5-dioxo-2'',3''-dihydrospiro[imidazolidine-4,1''-inden]-1-yl]-N-[3-(trifluoromethyl)oxetan-3-yl]acetamide::US20250263415, Example 1

SMILES O=C(CN6C(=O)N[C@]5(CCc4cc(C3C=NN(C2CN(C1COC1)C2)C3)ccc45)C6=O)N(Cc7ccc(F)cc7)C8(C(F)(F)F)COC8

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 766044   

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM766044(N-[(4-fluorophenyl)methyl]-2-[(1'S)-5'-{1-[1-(oxet...)
Affinity DataIC50: 16nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent